201 East Kennedy Blvd
Suite 700
Tampa, FL 33602
United States
844 633 6839
https://innoverenscientific.com
Settore/i: Healthcare
Settore: Biotechnology
Impiegati a tempo pieno: 2
Nome | Titolo | Retribuzione | Esercitate | Anno di nascita |
---|---|---|---|---|
Mr. Michael W. Yurkowsky | CEO & Director | 180k | N/D | 1972 |
Mr. Jeremy D. Daniel | Chief Financial Officer | 200k | N/D | 1977 |
Dr. Tanya Rhodes Ph.D. | Chief Scientific Officer | 252k | N/D | 1961 |
Mr. Jeffery Wright CPA, CPA | Controller & Principal Accounting Officer | N/D | N/D | 1983 |
Innoveren Scientific Inc., a medical bioscience company that develops technology in regenerative medicine for limb salvage. It is also developing immunotherapies for ovarian cancer, pancreatic cancer, and mesothelioma. The company was formerly known as H-CYTE, Inc. and changed its name to Innoveren Scientific Inc. in July 2023. The company is headquartered in Tampa, Florida.
L'ISS Governance QualityScore di Innoveren Scientific Inc. al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.